Abdullaev Y, Posner MI, Nunnally R, Dishion TJ (2010) Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behav Brain Res 215:45–57. doi:
10.1016/j.bbr.2010.06.023
Article
PubMed
Google Scholar
Backes V, Kellermann T, Voss B, Krӓmer J, Depner C, Schneider F, Habel U (2011) Neural correlates of the attention network test in schizophrenia. Eur Arch Psychiatry Clin Neurosci 261(Supple 2):S155–S160. doi:
10.1007/s00406-011-0264-9
Article
PubMed
Google Scholar
Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory, 2nd edn. Pearson, Texas
Google Scholar
Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33–84. doi:
10.1016/S0165-0173(03)00143-7
Article
PubMed
Google Scholar
Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218. doi:
10.1111/j.2044-8341.1974.tb02285.x
Article
Google Scholar
Caviola L, Faber NS (2015) Pills or push-ups? Effectiveness and public perception of pharmacological and non-pharmacological cognitive enhancement. Front Psychol 6:1852. doi:
10.3389/fpsyg.2015.01852
Article
PubMed
PubMed Central
Google Scholar
Conen S, Theunissen EL, Vermeeren A, van Ruitenbeek P, Stiers P, Mehta MA, Toennes SW, Ramaekers JG (2013) The role of P-glycoprotein in CNS antihistamine effects. Psychopharmacology 229:9–19. doi:
10.1007/s00213-013-3075-z
Article
CAS
PubMed
Google Scholar
Corbetta M, Shulman GL (2002) Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 3:201–215. doi:
10.1038/nrn755
Article
CAS
PubMed
Google Scholar
Coull JT, Nobre AC, Frith CD (2001) The noradrenergic α2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb Cortex 11:73–84. doi:
10.1093/cercor/11.1.73
Article
CAS
PubMed
Google Scholar
del Campo N, Fryer TD, Hong YT, Smith R, Brichard L, Acosta-Cabronero J, Chamberlain SR, Tait R, Izquierdo D, Regenthal R, Dowson J, Suckling J, Baron JC, Aigbirhio FI, Robbins TW, Sahakian BJ, Müller U (2013) A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. Brain 136:3252–3270. doi:
10.1093/brain/awt263
Article
PubMed
PubMed Central
Google Scholar
Devoto P, Flore G (2006) On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? Curr Neuropharmacol 4:115–125. doi:
10.2174/157015906776359559
Article
CAS
PubMed
PubMed Central
Google Scholar
Devoto P, Flore G, Pira L, Longu G, Gessa GL (2004) Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487:105–111. doi:
10.1016/j.ejphar.2004.01.018
Article
CAS
PubMed
Google Scholar
Fan J, McCandliss BD, Sommer T, Raz A, Posner MI (2002) Testing the efficiency and independence of attentional networks. J Cogn Neurosci 14:340–347. doi:
10.1162/089892902317361886
Article
PubMed
Google Scholar
Fan J, McCandliss BD, Fossella J, Flombaum JI, Posner MI (2005) The activation of attentional networks. NeuroImage 26:471–479. doi:
10.1016/j.neuroimage.2005.02.004
Article
PubMed
Google Scholar
Ferraro L, Antonelli T, Tanganelli S, O’Connor WT, Perez de la Mora M, Mendez-Franco J, Rambert FA, Fuxe K (1999) The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABA
A
receptor blockade. Neuropsychopharmacology 20:346–356. doi:
10.1016/S0893-133X(98)00085-2
Article
CAS
PubMed
Google Scholar
Ferraro L, Fuxe K, Tanganelli S, Fernandez M, Rambert FA, Antonelli T (2000) Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil. Neuropharmacology 39:1974–1983. doi:
10.1016/S0028-3908(00)00019-8
Article
CAS
PubMed
Google Scholar
Green AE, Munafò MR, DeYoung CG, Fossella JA, Fan J, Gray JR (2008) Using genetic data in cognitive neuroscience: from growing pains to genuine insights. Nat Rev Neurosci 9:710–720. doi:
10.1038/nrn2461
Article
CAS
PubMed
Google Scholar
Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55. doi:
10.1111/j.2044-8341.1959.tb00467.x
Article
CAS
PubMed
Google Scholar
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62. doi:
10.1136/jnnp.23.1.56
Article
CAS
PubMed
PubMed Central
Google Scholar
Hart CL, Haney M, Vosburg SK, Comer SD, Gunderson E, Foltin RW (2006) Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology 31:1526–1536. doi:
10.1038/sj.npp.1300991
Article
CAS
PubMed
Google Scholar
Ikeda Y, Koeda M, Kim W, Tateno A, Okubo Y, Suzuki H (2012) Caffeine’s effects on attentional networks in healthy subjects: a pharmacological functional magnetic resonance imaging study. J Nippon Med Sch 79:318–319. doi:
10.1272/jnms.79.318
Article
PubMed
Google Scholar
Ishizuka T, Murotani T, Yamatodani A (2010) Modafinil activates the histaminergic system through the orexinergic neurons. Neurosci Lett 483:193–196. doi:
10.1016/j.neulet.2010.08.005
Article
CAS
PubMed
Google Scholar
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545
Article
CAS
PubMed
Google Scholar
Johnson KA, Robertson IH, Barry E, Mulligan A, Dáibhis A, Daly M, Watchorn A, Gill M, Bellgrove MA (2008) Impaired conflict resolution and alerting in children with ADHD: evidence from the attention network test (ANT). J Child Psychol Psychiatry 49:1339–1347. doi:
10.1111/j.1469-7610.2008.01936.x
Article
PubMed
Google Scholar
Kim W, Tateno A, Arakawa R, Sakayori T, Ikeda Y, Suzuki H, Okubo Y (2014)
In vivo
activity of modafinil on dopamine transporter measured with positron emission tomography and [
18
F]FE-PE2I. Int J Neuropsychopharmacol 17:697–703. doi:
10.1017/S1461145713001612
Article
CAS
PubMed
Google Scholar
Kratz O, Studer P, Baack J, Malcherek S, Erbe K, Moll GH, Heinrich H (2012) Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the attention network test. Prog Neuro-Psychopharmacol Biol Psychiatry 37:81–89. doi:
10.1016/j.pnpbp.2011.12.008
Article
CAS
Google Scholar
Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M (1992) Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591:319–326. doi:
10.1016/0006-8993(92)91713-O
Article
CAS
PubMed
Google Scholar
Liu K, Sun G, Li B, Jiang Q, Yang X, Li M, Li L, Qian S, Zhao L, Zhou Z, von Deneen KM, Liu Y (2013) The impact of passive hyperthermia on human attention networks: an fMRI study. Behav Brain Res 243:220–230. doi:
10.1016/j.bbr.2013.01.013
Article
PubMed
Google Scholar
Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miler GM, Fischman AJ (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319:561–569. doi:
10.1124/jpet.106.106583
Article
CAS
PubMed
Google Scholar
Marchant NL, Kamel F, Echlin K, Grice J, Lewis M, Rusted JM (2009) Modafinil improves rapid shifts of attention. Psychopharmacology 202:487–495. doi:
10.1007/s00213-008-1395-1
Article
CAS
PubMed
Google Scholar
McNair DM, Lorr M, Droppleman LF (1971) Manual for the Profile of Mood States. Educational and Industrial Testing Service, California
Mereu M, Bonci A, Newman AH, Tanda G (2013) The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology 229:415–434. doi:
10.1007/s00213-013-3232-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, Joëls M, Mansuy IM, Meyer-Lindenberg A, Murphy D, Rolls E, Saletu B, Spedding M, Sweeney J, Whittington M, Young LJ (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11:141–168. doi:
10.1038/nrd3628
Article
CAS
PubMed
Google Scholar
Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33:1477–1502. doi:
10.1038/sj.npp.1301534
Article
CAS
PubMed
Google Scholar
Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS (2008) Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. Science 322:1700–1702. doi:
10.1126/science.1164908
Article
CAS
PubMed
Google Scholar
Murillo-Rodríguez E, Haro R, Palomero-Rivero M, Millán-Aldaco D, Drucker-Colín R (2007) Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increased wakefulness in rats. Behav Brain Res 176:353–357. doi:
10.1016/j.bbr.2006.10.016
Article
PubMed
Google Scholar
Muto V, Shaffii-Le Bourdiec A, Matarazzo L, Foret A, Mascetti L, Jaspar M, Vandewalle G, Phillips C, Degueldre C, Balteau E, Luxen A, Collette F, Maquet P (2012) Influence of acute sleep loss on the neural correlates of alerting, orientating and executive attention components. J Sleep Res 21:648–658. doi:
10.1111/j.1365-2869.2012.01020.x
Article
PubMed
Google Scholar
Oberlin BG, Alford JL, Marrocco RT (2005) Normal attention orienting but abnormal stimulus alerting and conflict effect in combined subtype of ADHD. Behav Brain Res 165:1–11. doi:
10.1016/j.bbr.2005.06.041
Article
PubMed
Google Scholar
Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113. doi:
10.1016/0028-3932(71)90067-4
Article
CAS
PubMed
Google Scholar
Peñaloza RA, Sarkar U, Claman DM, Omachi TA (2013) Trends in on-label and off-label modafinil use in a nationally representative sample. JAMA Intern Med 173:704–706. doi:
10.1001/jamainternmed.2013.2807
Article
PubMed
Google Scholar
Pironti VA, Lai MC, Müller U, Dodds CM, Suckling J, Bullmore ET, Sahakian BJ (2014) Neuroanatomical abnormalities and cognitive impairments are shared by adults with attention-deficit/hyperactivity disorder and their unaffected first-degree relatives. Biol Psychiatry 76:639–647. doi:
10.1016/j.biopsych.2013.09.025
Article
PubMed
PubMed Central
Google Scholar
Posner MI, Petersen SE (1990) The attention system of the human brain. Annu Rev Neurosci 13:25–42. doi:
10.1146/annurev.neuro.13.1.25
Article
CAS
PubMed
Google Scholar
Posner MI, Rothbart MK (2007) Research on attention networks as a model for the integration of psychological science. Annu Rev Psychol 58:1–23. doi:
10.1146/annurev.psych.58.110405.085516
Article
PubMed
Google Scholar
Pringle A, Browning M, Parsons E, Cowen PJ, Harmer CJ (2013) Early markers of cognitive enhancement: developing an implicit measure of cognitive performance. Psychopharmacology 230:631–638. doi:
10.1007/s00213-013-3186-6
Article
CAS
PubMed
Google Scholar
Qu WM, Huang ZL, Xu XH, Matsumoto N, Urade Y (2008) Dopaminergic D
1
and D
2
receptors are essential for the arousal effect of modafinil. J Neurosci 28:8462–8469. doi:
10.1523/JNEUROSCI.1819-08.2008
Article
CAS
PubMed
Google Scholar
Randall DC, Shneerson JM, Plaha KK, File SE (2003) Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 18:163–173. doi:
10.1002/hup.456
Article
CAS
PubMed
Google Scholar
Randall DC, Shneerson JM, File SE (2005) Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav 82:133–139. doi:
10.1016/j.pbb.2005.07.019
Article
CAS
PubMed
Google Scholar
Rasetti R, Mattay VS, Stankevich B, Skjei K, Blasi G, Sambataro F, Arrillaga-Romany IC, Goldberg TE, Callicott JH, Apud JA, Weinberger DR (2010) Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology 35:2101–2109. doi:
10.1038/npp.2010.83
Article
CAS
PubMed
PubMed Central
Google Scholar
Repantis D, Schlattmann P, Laisney O, Heuser I (2010) Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 62:187–206. doi:
10.1016/j.phrs.2010.04.002
Article
CAS
PubMed
Google Scholar
Robertson P Jr, Hellriegel ET (2003) Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 42:123–137. doi:
10.2165/00003088-200342020-00002
Article
CAS
PubMed
Google Scholar
Rugino T (2007) A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. Neuropsychiatr Dis Treat 3:293–301
CAS
PubMed
PubMed Central
Google Scholar
Sarter M, Givens B, Bruno JP (2001) The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res Brain Res Rev 35:146–160. doi:
10.1016/S0165-0173(01)00044-3
Article
CAS
PubMed
Google Scholar
Schneider M, Retz W, Coogan A, Thome J, Rösler M (2006) Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)—a neurological view. Eur Arch Psychiatry Clin Neurosci 256:i32–i41. doi:
10.1007/s00406-006-1005-3
Article
PubMed
Google Scholar
Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C (2007) Synthesis of
11
C-labelled (
R
)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET. Bioorg Med Chem 15:616–625. doi:
10.1016/j.bmc.2006.10.065
Article
CAS
PubMed
Google Scholar
Schulz S, Arning L, Pinnow M, Epplen JT, Beste C (2012)
N
-methyl-
d
-aspartate receptor 2B subunit (
GRIN2B
) gene variation is associated with alerting, but not with orienting and conflicting in the attention network test. Neuropharmacology 63:259–265. doi:
10.1016/j.neuropharm.2012.02.024
Article
CAS
PubMed
Google Scholar
Shih MC, Hoexter MQ, de Andrade LAF, Bressan RA (2006) Parkinson’s disease and dopamine transporter neuroimaging—a critical review. Sao Paulo Med J 124:168–175. doi:
10.1590/S1516-31802006000300014
Article
PubMed
Google Scholar
Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory, STAI-form Y. Consulting Psychologists Press, California
Google Scholar
Sturm W, Willmes K (2001) On the functional neuroanatomy of intrinsic and phasic alertness. NeuroImage 14:S76–S84. doi:
10.1006/nimg.2001.0839
Article
CAS
PubMed
Google Scholar
Theunissen EL, Elvira Jde L, van den Bergh D, Ramaekers JG (2009) Comparing the stimulant effects of the H1-antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate. J Clin Psychopharmacol 29:439–443. doi:
10.1097/JCP.0b013e3181b3b5f3
Article
CAS
PubMed
Google Scholar
Thiel CM, Zilles K, Fink GR (2004) Cerebral correlates of alerting, orienting and reorienting of visuospatial attention: an event-related fMRI study. NeuroImage 21:318–328. doi:
10.1016/j.neuroimage.2003.08.044
Article
PubMed
Google Scholar
Thienel R, Voss B, Kellermann T, Reske M, Halfter S, Sheldrick AJ, Radenbach K, Habel U, Shah NJ, Schall U, Kircher T (2009) Nicotinic antagonist effects on functional attention networks. Int J Neuropsychopharmacol 12:1295–1305. doi:
10.1017/S1461145709990551
Article
CAS
PubMed
Google Scholar
Thimm M, Kircher T, Kellermann T, Markov V, Krach S, Jansen A, Zerres K, Eggermann T, Stöcker T, Shah NJ, Nöthen MM, Rietschel M, Witt SH, Mathiak K, Krug A (2011) Effects of a
CACNA1C
genotype on attention networks in healthy individuals. Psychol Med 41:1551–1561. doi:
10.1017/S0033291710002217
Article
CAS
PubMed
Google Scholar
Tohid H, Faizan M, Faizan U (2015) Alterations of the occipital lobe in schizophrenia. Neurosciences (Riyadh) 20:213–224. doi:
10.17712/nsj.2015.3.20140757
Article
Google Scholar
Turner D (2006) A review of the use of modafinil for attention-deficit hyperactivity disorder. Expert Rev Neurother 6:455–468. doi:
10.1586/14737175.6.4.455
Article
CAS
PubMed
Google Scholar
Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (2004) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29:1363–1373. doi:
10.1038/sj.npp.1300457
Article
CAS
PubMed
Google Scholar
Valentini V, Cacciapaglia F, Frau R, Di Chiara G (2006) Differential α
2
-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade. J Neurochem 98:113–121. doi:
10.1111/j.1471-4159.2006.03851.x
Article
CAS
PubMed
Google Scholar
Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K (2009) Effects of modafinil on dopamine an dopamine transporters in the male human brain: clinical implications. JAMA 301:1148–1154. doi:
10.1001/jama.2009.351
Article
CAS
PubMed
PubMed Central
Google Scholar
Vossel S, Geng JJ, Fink GR (2014) Dorsal and ventral attention systems: distinct neural circuits but collaborative roles. Neuroscientist 20:150–159. doi:
10.1177/1073858413494269
Article
PubMed
PubMed Central
Google Scholar
Wisor J (2013) Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions. Front Neurol 4:139. doi:
10.3389/fneur.2013.00139
Article
PubMed
PubMed Central
Google Scholar
Zheng J, Qin B, Dang C, Ye W, Chen Z, Yu L (2012) Alertness network in patients with temporal love epilepsy: a fMRI study. Epilepsy Res 100:67–73. doi:
10.1016/j.eplepsyres.2012.01.006
Article
PubMed
Google Scholar